Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
Lee, Y., Fang, Q., Wang, Z., Li, D., & Cook, C. (1991). Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers. (U.S. Patent No. 5064823). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=5064823
Abstract
Pentacyclic triterpenoid compounds such as .alpha. boswelic acid and its acetate, .beta.-boswellic acid and its acetate, which have an inhibitory effect on topoisomerase I and topoisomerase II, are disclosed. Compositions based on the pentacyclic triterpenoid compounds which can be used to treat various cancers in mammals are also disclosed.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.